Real-Time Ultrasound/MRI Fusion for Suprasacral Parallel Shift Approach to Lumbosacral Plexus Blockade and Analysis of Injectate Spread:An Exploratory Randomized Controlled Trial by Strid, Jennie Maria Christin et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Real-Time Ultrasound/MRI Fusion for Suprasacral Parallel Shift Approach to
Lumbosacral Plexus Blockade and Analysis of Injectate Spread
Strid, Jennie Maria Christin; Pedersen, Erik Morre; Al-Karradi, Sinan Naseer Hussain;
Bendtsen, Mathias Alrø Fichtner; Bjørn, Siska; Dam, Mette; Daugaard, Morten; Hansen,
Martin Sejr; Linnet, Katrine Danker; Børglum, Jens; Søballe, Kjeld; Bendtsen, Thomas
Fichtner
Published in:
BioMed Research International
DOI:
10.1155/2017/1873209
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Strid, J. M. C., Pedersen, E. M., Al-Karradi, S. N. H., Bendtsen, M. A. F., Bjørn, S., Dam, M., ... Bendtsen, T. F.
(2017). Real-Time Ultrasound/MRI Fusion for Suprasacral Parallel Shift Approach to Lumbosacral Plexus
Blockade and Analysis of Injectate Spread: An Exploratory Randomized Controlled Trial. BioMed Research
International, 2017, [1873209]. https://doi.org/10.1155/2017/1873209
Download date: 03. Feb. 2020
Clinical Study
Real-Time Ultrasound/MRI Fusion for Suprasacral Parallel Shift
Approach to Lumbosacral Plexus Blockade and Analysis of
Injectate Spread: An Exploratory Randomized Controlled Trial
Jennie Maria Christin Strid,1 Erik Morre Pedersen,2 Sinan Naseer Hussain Al-Karradi,3
Mathias Alrø Fichtner Bendtsen,4 Siska Bjørn,1,4 Mette Dam,5
Morten Daugaard,6 Martin Sejr Hansen,4 Katrine Danker Linnet,7
Jens Børglum,5 Kjeld Søballe,8 and Thomas Fichtner Bendtsen1
1Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark
2Department of Radiology, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus C, Denmark
3Department of Biomedicine, Faculty of Health, Aarhus University, Vennelyst Boulevard 4, 8000 Aarhus C, Denmark
4Medical Science, Faculty of Health, Aarhus University, Nordre Ringgade 1, 8000 Aarhus C, Denmark
5Department of Anesthesiology and Intensive Care Medicine, Zealand University Hospital, University of Copenhagen,
Sygehusvej 10, 4000 Roskilde, Denmark
6Department of Anesthesiology, Regional Hospital of Viborg, Heibergs Alle 4, 8800 Viborg, Denmark
7Department of Anesthesiology and Intensive Care Medicine, Slagelse Hospital, Ingemannsvej 18, 4200 Slagelse, Denmark
8Department of Orthopedic Surgery, Aarhus University Hospital, Tage-Hansens Gade 2, 8000 Aarhus C, Denmark
Correspondence should be addressed toThomas Fichtner Bendtsen; tfb@dadlnet.dk
Received 11 November 2016; Accepted 29 January 2017; Published 15 March 2017
Academic Editor: Tatsuo Nakamoto
Copyright © 2017 Jennie Maria Christin Strid et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Fused real-time ultrasound and magnetic resonance imaging (MRI) may be used to improve the accuracy of advanced image
guided procedures. However, its use in regional anesthesia is practically nonexistent. In this randomized controlled crossover trial,
we aim to explore effectiveness, procedure-related outcomes, injectate spread analyzed by MRI, and safety of ultrasound/MRI
fusion versus ultrasound guided Suprasacral Parallel Shift (SSPS) technique for lumbosacral plexus blockade. Twenty-six healthy
subjects aged 21–36 years received two SSPS blocks (20mL 2% lidocaine-epinephrine [1 : 200,000] added 1mL diluted contrast)
guided by ultrasound/MRI fusion versus ultrasound. Number (proportion) of subjects with motor blockade of the femoral and
obturator nerves and the lumbosacral trunk was equal (ultrasound/MRI, 23/26 [88%]; ultrasound, 23/26 [88%]; 𝑝 = 1.00).
Median (interquartile range) preparation and procedure times (s) were longer for the ultrasound/MRI fusion guided technique
(686 [552–1023] versus 196 [167–228], 𝑝 < 0.001 and 333 [254–439] versus 216 [176–294], 𝑝 = 0.001). Both techniques produced
perineural spread and corresponding sensory analgesia fromL2 to S1. Epidural spread and lidocaine pharmacokinetics were similar.
Different compartmentalized patterns of injectate spread were observed. Ultrasound/MRI fusion guided SSPS was equally effective
and safe but required prolonged time, compared to ultrasound guided SSPS.This trial is registered with EudraCT (2013-004013-41)
and ClinicalTrials.gov (NCT02593370).
1. Introduction
An effective, safe, and easy-to-perform peripheral nerve
block technique for surgical anesthesia of the hip joint and
concurrent postoperative analgesia would be advantageous,
because many of the patients admitted for hip fracture are
elderly, fragile, and sometimes impaired by severe cardiovas-
cular comorbidity [1].
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General and spinal anesthesia is associatedwith increased
hemodynamic instability, anesthesia related mortality, and
complications in old and multimorbid patients [2].
Compared to general and spinal anesthesia, more stable
hemodynamics, fewer complications, and superior postop-
erative pain relief are achieved with peripheral regional
anesthesia with a minimal use of opioids [3–6].
The femoral and obturator nerves are the terminal nerves
of the lumbar plexus that innervate the hip joint together with
the lumbosacral trunk of the sacral plexus. All these nerves
can be anesthetized with a single injection paravertebrally
between the transverse process of the fifth lumbar (L5) verte-
bra and the cranial border of the sacral ala [7, 8]. However, the
accuracy of targeting the nerves with an ultrasound guided
injection may be impaired due to the deep location of the
target nerves as well as the lumbosacral bony structures
generating acoustic shadows impeding the visibility of the
needle trajectory [9], especially in old, fragile, comorbid, or
obese patients [10–13]. Consequently, the efficiency and safety
of the blockade may be undesirably affected and epidural
spread of the injectate [9] as well as vascular, neural, or
muscular injury may occur.
The accuracy of image guided procedures may be
improved by fusing real-time ultrasound withmagnetic reso-
nance imaging (MRI) thus defeating the limitations of ultra-
sonography as a stand-alone technique [14, 15]. Furthermore,
the image fusion technology includes electromagnetic needle
tip tracking, which allows the operator to continuously assess
the best needle insertion point, the needle trajectory, and
the target of the injection. Finally, image fusion can be used
to better the understanding of (ultrasonographic) anatomy
and needle guidance and to refine existing ultrasound guided
needle techniques [16]. Fusion of real-time ultrasound and
computer tomography (CT) or MRI has been used success-
fully especially in interventional radiology [14, 15]. In regional
anesthesia, an application of fused ultrasound/CT or MRI of
the lumbar spine has been briefly described in a phantom and
in volunteers, respectively, but no injections were performed
[17]. In chronic pain therapy, only a few cadaver and case
reports have assessed ultrasound/CT or MRI fusion guided
injections primarily of the sacroiliac joint, hand, and wrist
[18–21].
In this exploratory randomized controlled crossover trial,
we aim to investigate real-time ultrasound/MRI fusion versus
ultrasound guidance applied on the Suprasacral Parallel
Shift (SSPS) technique for lumbosacral plexus blockade [22].
Primary outcome is the proportion of study subjects with
motor blockade of the femoral and obturator nerves as well as
the lumbosacral trunk. Secondary outcomes are procedure-
related, perineural spread of injectate analyzed by MRI,
epidural spread, sensory blockade, lidocaine pharmacokinet-
ics, and cost-effectiveness. In addition, we aim to explore
compartmentalized patterns of injectate spread by MRI.
2. Methods and Materials
2.1. Ethics. The Regional Research Ethics Committee (MJ:
1-10-72-179-13), the Danish Medicines Agency (2013-004013-
13), and the Danish Data Protection Agency (1-16-02-160-14)
approved this randomized controlled crossover trial. The
study was registered in EudraCT (2013-004013-41) and in
ClinicalTrials.gov (NCT02593370), monitored by the Good
Clinical Practice unit at Aalborg and Aarhus University
Hospitals, and complied with the Helsinki Declaration.
Written informed consent was obtained from all subjects.
2.2. Recruitment. ASA I subjects aged ≥18 years were
recruited through a Danish website for research volunteers.
Subjects who were non-Danish speakers or unable to coop-
erate, had a history of allergy to local anesthetics or contrast
agents, daily consumption of analgesics, abuse of medicine or
alcohol, contraindication toMRI or infection or prior surgery
of the paravertebral lumbosacral region, or who were legally
incompetent were excluded.
The studywas conducted at theDepartment of Radiology,
Aarhus University Hospital, in Denmark during two three-
day sessions with a one-week interim period in October
to November 2015. The volunteers received payment for
participation.
2.3. MRI for Fusion with Ultrasound. An experienced radio-
grapher recorded supine MRI scans of all subjects with
a 1.5 T Philips Ingenia MRI scanner (Koninklijke Philips
Electronics NV, Eindhoven, Netherlands) upon arrival on
the first session. The subjects were scanned with a pillow
under their knees to minimise lumbar lordosis and a dS flex
coverage anterior coil for signal reception. The recordings of
the lumbar spine were coronal 3D T2-TSE sequences with an
scanning resolution of 1.00 × 1.00 × 2.00mm3 (overlapping
2.40mm slices, 1.20 spacing), TE 60ms, and TR 1200ms. A
feet-head phase encoding was applied to minimise artifacts
due to respiration and peristalsis. All sequences were recon-
structed to 0.78 × 0.78 × 1.00mm3 resolution and converted
to axial orientation usingOsiriX v6.5.2 64-bit (Pixmeo SARL,
Bernex, Switzerland) prior to upload to the ultrasound system
with image fusion software (Epiq 7 1.4; Koninklijke Philips
ElectronicsNV, Eindhoven,Netherlands), because the system
only accepts axially oriented datasets for fusion.
2.4. Lumbosacral Plexus Block Procedure. The subjects were
monitored with three-lead ECG, noninvasive blood pressure
measurement, and pulse oximetry. Peripheral intravenous
access was established for blood sampling and safety.
All blocks were performed with the Epiq 7 1.4 ultrasound
system. The regional anesthetist (TFB) who performed all
blocks has extensive clinical experience with ultrasound
and electrical nerve stimulation guided nerve blocks and
experimental experience with ultrasound/MRI fusion guided
lumbosacral procedures.
While performing all blocks, the field generator (Konin-
klijke Philips Electronics NV, Eindhoven, Netherlands) was
positioned over the lumbosacral region to generate the
electromagnetic field necessary for fusion or to strengthen
blinding of the subjects. After prescanning and any coregis-
tration of ultrasound and MRI, the skin was swapped with
chlorhexidine in isopropyl alcohol and covered with a sterile
fenestrated drape. The curved array ultrasound probe (C5-1;
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Figure 1: The ultrasonographic (a) and MR (b) images are fused and displayed side-by-side. The blue line in the top is the projection of the
block needle and the large green circle marks the anticipated intersection of the block needle tip and the ultrasound beam, here coinciding
with the rami of spinal nerve L5 (yellow arrow) displayed on the MR image. The line of small blue and yellow dots marks the anticipated
trajectory of the block needle prior to and after the intersection with the ultrasound beam, respectively. PMM, major psoas muscle; S, sacral
ala; TP L4-5, transverse processes of the fourth and fifth lumbar vertebral bodies.
Koninklijke Philips ElectronicsNV, Eindhoven,Netherlands)
with the attached sensor was draped with a sterile cover.
The skin and subcutaneous tissue were infiltrated with 2mL
2% lidocaine prior to insertion of a 22 Gauge, 100mm
nerve block needle (Stimuplex Ultra; B. Braun, Melsungen,
Germany). The injectate of each nerve block was 20mL 2%
lidocaine-epinephrine [1 : 200,000] with 1mL diluted MRI
contrast (0.13mL 27.9% gadoterate meglumine [Dotarem;
Guerbet, Roissy CdG Cedex, France] and 0.87mL 0.9%
isotonic saline) added.
Ultrasound/MRI Fusion Guided SSPS. The subject was placed
supine. The patient tracker, serving as a reference for the
sensors mounted on the probe and the block needle, was
affixed to the subject’s iliac crest with adhesive tape on the
side to be anesthetized. The probe was oriented axially on
the abdomen. An identical reference point in the axial plane
at the bifurcation of the common iliac arteries was used
for coregistration of the real-time ultrasound and the MRI
dataset. After coregistration, the ultrasonographic and MR
images moved synchronically with any movement of the
probe. The images were aligned using the iliac arteries, the
aortic bifurcation, and the anterior margin of the lumbar
vertebral body at the same level. Next, the subject was
turned to the lateral decubitus position with the side to be
anesthetized facing upwards. In order to take account for any
misalignment due to the position change, the alignment of
the fused datasets was fine adjusted using the borders of the
L5 transverse process and vertebral body as well as the posi-
tions of the psoas major, quadratus lumborum, and erector
spinae muscles. The probe was placed in the sagittal plane
across the caudal border of the transverse process of L5 and
the cranial border of the sacral ala, visualizing the interspace
(osteofibrotic tunnel) in-between the bony structures on
both images. Based on ultrasound/MRI visualization of the
intertransverse ligament (posteriorly) and the lumbosacral
ligament (anteriorly) marking out the osteofibrotic tunnel,
the tip of the block needle was placed in the anticipated
position for needle insertion caudad to the intercristal line.
Using needle navigation, the position and angle of the
insertion were adjusted until the anticipated intersection of
the needle tip and the ultrasound beam coincided with the
target compartment posterior to the psoasmajormuscle [8, 9]
displayed on the MR image (Figure 1). Guided by real-time
ultrasound/MRI fusion and needle navigation, the needle
was advanced with an out-of-plane technique until a “loss of
resistance” confirmed the visualized penetration through the
lumbosacral ligament and the needle tip position anterior to
the ligament on MRI.
Ultrasound Guided SSPS. This technique was performed in
the lateral decubitus position and has been described in-
depth previously [9]. The endpoint of injection was “loss of
resistance” confirming the needle penetration of the lumbo-
sacral ligament, sonographically visualized if possible.
An electrical nerve stimulator (0.1ms, 2Hz, 0.2mA) was
connected to the block needle during both procedures in
order to decrease the risk of intraneural injection of local
anesthetics. Prior to injection, any response to electrical
nerve stimulation with 0.3 to 0.5mA was registered [23]. The
electrical nerve stimulationwas use for safety only, not needle
guidance.The local anesthetic with contrast was injectedwith
intermittent aspiration.
Time zero (𝑇0) min was the time of withdrawal of the
block needle from the skin after completed injection. All
subjects were followed up until 𝑇90 for data sampling and
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were observed for adverse effects until the sensorimotor
blockade had worn off.
2.5. Outcomes and Assessment. Theprimary outcomewas the
proportion of subjects with motor blockade of the femoral
and obturator nerves as well as the lumbosacral trunk. Motor
blockade was defined as ≥1 N reduction in muscle force (N)
of the knee extensors, hip adductors, and hip abductors,
respectively, at 𝑇40 compared to baseline. Muscle force was
estimated in the supine position with a dynamometer (Com-
mander Muscle Testing; JTECH Medical, Midvale, USA)
maintained immobile by a steady grip of an observer. The
observer instructed the subject to exert maximal pressure
against the dynamometer during knee extension (with 90∘
flexion of the hip and knee joints), hip adduction (with
extended and 45∘ abducted lower limb), and hip abduction
(with extended lower limb). The highest value of three tests
with 20 s intermittent intervals was recorded for eachmotion.
The secondary outcomes were (a) preparation time (s)
from positioning of the subject on the bed until end of
prescanning and coregistration, if any; (b) block procedure
time (s) from placement of the probe on the skin until
withdrawal of the block needle after completed injection;
(c) number of needle insertions defined as each withdrawal
of the needle followed by an advancement regardless the
number of skin penetrations; (d) needle insertion point
defined as the horizontal distance (cm) from the median
to the skin penetration; (e) depth of needle tip gauged
by reading the distance (cm) marked on the needle shaft
at the endpoint of the injection; (f) minimal electrical
nerve stimulation (mA) required to trigger any sensorimotor
response immediately prior to injection; (g) type of response
to electrical nerve stimulation (“Quadriceps,” “Adductor,”
“Other motor,” “Paresthesia,” and “None”); (h) maximum
procedural discomfort assessed by the subject on a numeric
rating scale (NRS, 0 = “no discomfort”, 10 = “worst possible
discomfort”) at 𝑇0; (i) change in mean arterial blood pressure
(ΔMAP) from baseline to 𝑇5; (j) perineural injectate spread;
(k) epidural injectate spread; (l) sensory blockade; (m) maxi-
mumplasma concentration of lidocaine (𝐶max of p-lidocaine,
𝜇g/mL); (n) time to 𝐶max (𝑇omc) of p-lidocaine (min); (o) p-
lidocaine concentration-time area under the curve; and (p)
cost-effectiveness.
Injectate spread was analyzed on axial 3D T1-weighted
MRI sequences (mDixonAll generating in-phase, out-of-
phase, water and fat images as well as diffusion weighted
images) sampled with a Philips Achieva 3.0 T dstream scan-
ner (Koninklijke Philips Electronics, Eindhoven, Nether-
lands) at 𝑇15. Perineural spread was assessed for the anterior
rami of spinal nerves L2-S1, the femoral, obturator, and
lateral femoral cutaneous nerves as well as the lumbosacral
trunk. Perineural spread was considered “present” when
direct contact between the injectate and the target nerve was
visualized.
As an exploratory analysis, we observed different patterns
of confinement of injectate inside the fascial compartments
medial, posterior, and lateral to the psoas major muscle,
respectively, as well as associated spread of injectate around
compartment-specific nerves.
Epidural spreadwas considered “present” when there was
circumferential epidural distribution of the injectate on any
axial MRI level and concomitant bilateral blockade of cold in
at least one pair of dermatomes.
Sensory blockade of cold, warmth, touch, and pain of
the dermatomes Th12-S3 [24] and the skin innervated by the
lateral femoral cutaneous nerve was tested with standardized
stimuli (25∘ and 40∘ thermo test [Rolltemp II; Somedic,
Ho¨rby, Sweden], brush [SENSELab Brush-05; Somedic
AB, Ho¨rby, Sweden], and punctuated pin prick [PinPrick
512mN; MRC Systems GmbH, Heidelberg, Germany]) at
𝑇50. Sensation for each stimulus was assessed as “present” or
“reduced/absent,” where “reduced/absent” was considered a
successful sensory blockade. The dermatomes Th12, L1, S2,
and S3 were included in order to assess the effect of any
epidural spread.
For the analysis of p-lidocaine, blood samples were
collected at 𝑇0,5,10,20,40,60, and 90 and centrifuged at 1, 800𝑔 for
9min. The plasma was transferred to 1.5mL cryotubes and
stored at −80∘C until analysis with liquid chromatography
tandem mass spectrometry [25].
The difference in mean marginal cost of the inter-
ventions was calculated as a measure of cost-effectiveness
(extra price per patient) [26]. Unit costs were collected in
Danish Kroner (DKK) in July 2016 and converted into US
dollars (GBP/euros) in October 2016 (100DKK = $14.86
[m12.08/€13.44]). Average annual total wages were used to
calculate unit costs for time spent by medical staff. Because
of the complexity of calculating the expense for the 1.5 TMRI
scanner use, this cost is given as a time unit.
2.6. Randomization and Blinding. JMCS enrolled all subjects.
Two study-independent assistants randomly allocated 26
consecutive subject identification numbers to sequences of
interventions (Ultrasound/MRI fusion guided SSPS on day
one and ultrasound guided SSPS on day two or vice versa)
and side (right on day one and left on day two or vice versa).
Twenty-six sheets with the sequences preprinted were put in
26 identical opaque and sealed envelopes marked 1 to 26.
TFB and SB double-checked the allocated intervention and
side immediately prior to each procedure without revealing
it to others. The sheet was reenveloped and resealed. The
procedure was repeated prior to the second intervention.
All sampling and analyses of data were blinded to the
intervention. All interventionswere performedwith identical
trial setup and equipment in order to blind the subjects.
The MRI records of injectate spread were anonymised by a
radiographer and hereafter analyzed in a random order by
TFB.
2.7. Statistics. The primary outcome was proportion of sub-
jectswithmotor blockade of the femoral and obturator nerves
aswell as the lumbosacral trunk.Wehypothesized an increase
in the proportion from 75% with ultrasound guidance to
100% with ultrasound/MRI fusion guidance. Detection of a
25% increase with 80% power (1 − 𝛽) and 𝛼 = 0.05 would
require a sample size of 24 subjects in a two-sided crossover
analysis [27]. To avoid decreased power due to dropouts, we
included 26 subjects.
BioMed Research International 5
Assessed for eligibility (n = 26)
Randomized (n = 26)
Allocated to US guided SSPS (n = 13)
(i) Received allocated intervention (n = 13)
(ii) Did not receive allocated intervention (n = 0) 
Discontinued intervention (n = 0)
Analysed (n = 13)
(i) Primary outcome (n = 13) 
(ii) Secondary outcomes (n = 13)
Discontinued intervention (n = 1)
Analysed (n = 13)
(i) Primary outcome (n = 13) 
Allocated to US guided SSPS (n = 13)
(i) Received allocated intervention (n = 13)
(ii) Did not receive allocated intervention (n = 0) 
Allocated to US/MRI guided SSPS (n = 13)
(i) Received allocated intervention (n = 13)
(ii) Did not receive allocated intervention (n = 0) 
Allocated to US/MRI guided SSPS (n = 13)
(i) Received allocated intervention (n = 13)
(ii) Did not receive allocated intervention (n = 0) 
Discontinued intervention (n = 0)
Analysed (n = 13)
(i) Primary outcome (n = 13)
(ii) Secondary outcomes (n = 13)
Discontinued intervention (n = 0)
Analysed (n = 13)
(i) Primary outcome (n = 13)
(ii) Secondary outcomes (n = 13)
See text for details.
(ii) Secondary outcomes (n = 13)
Figure 2:Modified CONSORT 2010 flow diagram of the study subjects receiving ultrasound (US)/magnetic resonance imaging (MRI) fusion
versus US guided lumbosacral plexus blockade with the Suprasacral Parallel Shift (SSPS) technique.
Statistics were analyzed with Stata IC 14 (StataCorp LP,
College Station,USA).Normality of distributionwas assessed
visually with the normal Q-Q-plot. Normally distributed
differences between paired continuous variables were ana-
lyzed with one-sample Student’s 𝑡-test. Nonnormally dis-
tributed differences between paired continuous variables and
differences between paired ordinal variables were analyzed
with Wilcoxon matched-pairs signed rank test. Differences
between paired categorical variables were analyzed with
McNemar’s test. The level of significance was 0.05. Data are
presented as mean (standard deviation [SD]) for continuous
variables with normal distribution, as median (interquartile
range [IQR] [range]) for continuous variables with non-
normal distribution and ordinal variables, and as number
(proportion) for categorical variables.
3. Results
Twenty-six subjects (14/26 [54%] males) were enrolled dur-
ing October 3 to 24, 2015 (Figure 2). Twenty-five subjects
completed both interventions and follow-up per protocol.
One ultrasound guided SSPS intervention was aborted due to
aspiration of blood, but the subject completed the follow-up
and contributed with his data per protocol.
The median (IQR [range]) age for all 26 subjects was 22
(22–24 [21–36]) years, mean (SD) weight was 73.2 (11.7) kg,
mean (SD) height was 178 (8.1) cm, and mean (SD) BMI was
23.4 (2.7) kg⋅m−2.
The number (proportion) of subjects with motor block-
ade of the femoral and obturator nerves as well as the
lumbosacral trunk was equal (ultrasound/MRI, 23/26 [88%];
ultrasound, 23/26 [88%]; 𝑝 = 1.00). Table 1 displays the
underlying data on muscle force and the number (propor-
tion) ofmotor blockade of the femoral nerve, obturator nerve,
and lumbosacral trunk, respectively.
Table 2 displays the values of the procedure-related
outcomes.
There was no evidence for any difference in perineural
spread to the anterior rami of spinal nerves L2 (ultra-
sound/MRI, 14/26 [54%]; ultrasound, 11/26 [42%]; 𝑝 =
0.58), L3 (ultrasound/MRI, 21/26 [81%]; ultrasound, 21/26
[81%]; 𝑝 = 1.00), L4 (ultrasound/MRI, 22/26 [85%];
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Table 1: Baseline and postblock muscle force as well as number of subjects with motor blockade of the femoral nerve, obturator nerve, and
the lumbosacral trunk for ultrasound/MRI fusion guided versus ultrasound guided lumbosacral plexus blockade with the Suprasacral Parallel
Shift technique. Values are displayed as median (IQR [range]) or number (proportion).
US∗/MRI† US†
(𝑛 = 26) (𝑛 = 26)
Femoral nerve (knee extension)
Baseline muscle force; N 244 (204–266 [176–343]) 229 (215–253 [136–374])
Postblock muscle force; N 75 (0–121 [0–244]) 72 (0–134 [0–255])
Motor blockade 25 (96%) 24 (92%)
Obturator nerve (hip adduction)
Baseline muscle force; N 138 (114–176 [105–255]) 134 (114–176 [101–237])
Postblock muscle force; N 0 (0–70 [0–149]) 0 (0–31 [0–209])
Motor blockade 25 (96%) 24 (92%)
Lumbosacral trunk (hip abduction)
Baseline muscle force; N 147 (114–160 [79-204]) 144 (114–167 [79–233])
Postblock muscle force; N 79 (35–105 [0–173]) 54 (41–79 [0–169])
Motor blockade 24 (92%) 24 (92%)
Motor blockade was defined as a decrease in postblock muscle force compared to baseline.
∗US: ultrasound.
†MRI: magnetic resonance imaging.
Table 2: Procedure-related outcomes for ultrasound/MRI fusion guided versus ultrasound guided lumbosacral plexus blockade with the
Suprasacral Parallel Shift technique. Values are displayed as median (IQR [range]), number (proportion), or mean (SD).
US∗/MRI† US
𝑝
(𝑛 = 26) (𝑛 = 26)
Preparation time; s 686 (552–1023 [393–2501]) 196 (167–228 [105–351]) <0.001
Block procedure time; s 333 (254–439 [201–1421]) 216 (176–294 [117–458]) 0.001
Number of needle insertions 4.5 (3.0–7.0 [2.0–24.0]) 5.0 (3.0–7.0 [2.0–15.0]) 0.87
Needle insertion point from midline; cm 4.0 (4.0–5.0 [2.0–6.0]) 6.0 (5.0–6.0 [4.0–8.0]) <0.001
Needle depth; cm 8.0 (7.0–9.0 [5.0–10.0]) 8.0 (7.0–8.5 [4.0–10.0]) 0.37
Minimal nerve stimulation; mA 0.50 (0.50–0.50 [0.20–0.60]) 0.50 (0.40–0.50 [0.30–0.50]) 0.075
Electrical nerve stimulation response 0.37
1 Quadriceps femoris 4 (15%) 4 (15%) 1.00
2 Adductor 0 (0%) 1 (4%) 1.00
3 Other motor 0 (0%) 0 (0%) 1.00
4 Paresthesia 2 (8%) 0 (0%) 0.50
0 None 20 (77%) 21 (81%) 1.00
Procedural discomfort; NRS 0–10‡ 2 (1–3 [0–7]) 3 (2–4 [0–5]) 0.036
ΔMAP; mmHg§ 0.23 (12.77) −4.50 (10.44) 0.070
∗US: ultrasound.
†MRI: magnetic resonance imaging.
‡NRS: numeric rating scale.
§
ΔMAP: change in mean arterial pressure from baseline to 5 min after completed injection of local anesthetic.
ultrasound, 25/26 [96%]; 𝑝 = 0.38), L5 (ultrasound/MRI,
10/26 [38%]; ultrasound, 18/26 [69%]; 𝑝 = 0.057), and S1
(ultrasound/MRI, 5/26 [19%]; ultrasound, 8/26 [31%]; 𝑝 =
0.55), the femoral (ultrasound/MRI, 16/26 [62%]; ultrasound,
13/26 [50%]; 𝑝 = 0.61), obturator (ultrasound/MRI, 14/26
[73%]; ultrasound, 11/26 [85%]; 𝑝 = 0.58), and lateral femoral
cutaneous (ultrasound/MRI, 16/26 [62%]; ultrasound, 11/26
[42%]; 𝑝 = 0.58) nerves, or the lumbosacral trunk (ultra-
sound/MRI, 10/26 [38%]; ultrasound, 15/26 [58%]; 𝑝 = 0.58).
We identified characteristic patterns of compartmental-
ized injectate spread inside three compartments (Figures 3, 4
and 5).
No difference in compartmentalized spread of injectate
was observed between the two study groups.The frequencies
of compartmentalized spread of injectate in the entire popu-
lation of volunteerswere 27% into the parapsoas compartment
(PPC) and retropsoas subcompartment (RPSC), 27% into the
PPC, 37% into the RPSC, and 9% into the retroperitoneal
BioMed Research International 7
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Figure 3: MRI of one subject visualizing spread of lidocaine-epinephrine added diluted contrast (magenta arrow) primarily medial to the
psoas major muscle (PMM), that is, in the parapsoas compartment. (a) Sagittal plane. (b) Axial plane. (c) Coronal plane. Line (blue), position
of coronal plane; Line (orange), position of sagittal plane; Line (purple), position of axial plane; S, sacral ala; VB L5, fifth lumbar vertebral
body.
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Figure 4: MRI of one subject visualizing spread of lidocaine-epinephrine added diluted contrast (magenta arrow) primarily posterior to the
psoas major muscle (PPM), that is, in the retropsoas subcompartment, with minor seeping into the fascial plane between the anterior and
posterior (red arrow) lamina of the PMM that contains the lumbar plexus. (a) Sagittal plane. (b) Axial plane. (c) Coronal plane. L5, fifth
lumbar vertebral body; Line (blue), position of coronal plane; Line (orange), position of sagittal plane; Line (purple), position of axial plane;
S, sacral ala.
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Figure 5: MRI of one subject visualizing spread of lidocaine-epinephrine added diluted contrast (magenta arrow) primarily lateral to the
psoas major muscle (PMM), that is, in the retroperitoneal compartment, with minor seeping into the retropsoas subcompartment. (a) Sagittal
plane. (b) Axial plane. (c) Coronal plane. Line (blue), position of coronal plane; Line (orange), position of sagittal plane; Line (purple), position
of axial plane; S, sacral ala; VB L5, fifth lumbar vertebral body.
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Table 3: Number of subjects with sensory blockade of the dermatomesTh12-S3 and the skin area innervated by the lateral femoral cutaneous
nerve after ultrasound/MRI fusion guided (𝑛 = 26) versus ultrasound guided (𝑛 = 26) lumbosacral plexus blockade with the Suprasacral
Parallel Shift technique. Values are displayed as number (proportion).
Cold Warmth Touch Pain
US∗/MRI† US 𝑝 US/MRI US 𝑝 US/MRI US 𝑝 US/MRI US 𝑝
Th12 2 (8%) 0 (0%) 0.50 1 (4%) 1 (4%) 1.00 4 (15%) 1 (4%) 0.38 7 (8%) 2 (8%) 1.00
L1 4 (15%) 3 (12%) 1.00 2 (12%) 4 (15%) 1.00 9 (35%) 6 (23%) 0.55 7 (27%) 4 (15%) 0.51
L2 8 (31%) 10 (38%) 0.79 9 (35%) 10 (38%) 1.00 9 (35%) 11 (42%) 0.80 12 (46%) 11 (42%) 1.00
L3 18 (69%) 16 (62%) 0.75 13 (50%) 16 (42%) 0.58 7 (27%) 9 (35%) 0.75 15 (58%) 9 (35%) 0.18
L4 18 (69%) 15 (58%) 0.61 17 (65%) 14 (54%) 0.61 13 (50%) 13 (50%) 1.00 13 (50%) 14 (54%) 1.00
L5 10 (38%) 11 (42%) 1.00 9 (35%) 12 (46%) 0.55 8 (31%) 10 (38%) 0.75 8 (31%) 10 (38%) 0.75
S1 16 (62%) 14 (54%) 0.63 16 (52%) 18 (69%) 0.69 3 (12%) 10 (38%) 0.016 8 (31%) 12 (46%) 0.39
S2 5 (19%) 7 (27%) 0.75 7 (27%) 10 (38%) 0.55 8 (31%) 7 (27%) 1.00 7 (27%) 6 (23%) 1.00
S3 5 (19%) 8 (27%) 0.75 5 (19%) 7 (27%) 0.75 7 (27%) 9 (25%) 0.77 7 (27%) 8 (31%) 1.00
LFCN‡ 13 (50%) 9 (35%) 0.39 14 (54%) 10 (38%) 0.34 16 (62%) 10 (38%) 0.18 17 (65%) 10 (38%) 0.092
∗US: ultrasound.
†MRI: magnetic resonance imaging.
‡LFCN: lateral femoral cutaneous nerve.
compartment (RC). Seeping of injectate into the intrapsoas
compartment, that is, the compartment between the anterior
and posterior lamina of the psoas major muscle, and to the
L2–L4 part of the lumbar plexus occurred in 89% of RPSC
injection, 50% of PPC injection, and 40% of RC injection.
Table 3 displays the values of sensory blockade of the
dermatomesTh12-S3 and the lateral femoral cutaneous nerve.
There was no evidence for any difference in epidural
spread (ultrasound/MRI 3/26 (12%) subjects; ultrasound,
5/26 (19%) subjects; 𝑝 = 0.73). The sensory effect was
observed in the dermatomes L1 to S3 with individual varia-
tion.
Figure 6 illustrates the mean (SD) 𝐶max of p-lidocaine.
There was no evidence for any difference in mean (SD) 𝐶max,
median (IQR [range]) 𝑇omc, or mean (SD) concentration-
time area under the curve (Figure 6). One subject in the
ultrasound group was excluded from the analysis due to
insufficient blood sampling.
The mean marginal cost of a SSPS block was Δ/$28.19
(m22.91/€23.60) and 6min and 34 s in the 1.5 T MRI scanner
for the ultrasound/MRI fusion guided procedure compared
to the ultrasound guided.
No serious adverse events were observed. One subject
experienced a transitory hot flush prior to the intervention
due to vasovagal needle phobia. Four subjects had two inci-
dents of vasovagal syncope and three incidents of dizziness;
two were related to reinsertion of an intravenous catheter or
blood sampling during the follow-up; and one was related to
previously diagnosed orthostatic hypotension.
4. Discussion
This is the first randomized controlled trial investigating
ultrasound/MRI fusion guided lumbosacral plexus blockade.
We found that the ultrasound/MRI fusion guided technique
was equally effective and safe, but required longer preparation
and block procedure time compared to the ultrasound guided
technique.
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Figure 6: Plasma concentration of lidocaine 0 to 90min after
injection with the ultrasound/MRI fusion guided (US/MRI) versus
the ultrasound guided (US) Suprasacral Parallel Shift technique for
lumbosacral plexus blockade (𝑛 = 25). Values are presented asmean
(SD).
4.1. Block Success. The initial hypothesis of a higher pro-
portion of subjects with motor blockade of the femoral
and obturator nerves as well as the lumbosacral trunk with
ultrasound/MRI fusion guidance compared to ultrasound
guidance was falsified. This may be explained by the demo-
graphics of the study subjects. That is, the target clinical
group would be elderly and fragile patients, in whom the
ultrasonoanatomical image quality may be impaired and in
whom additional MRI visualization and needle navigation
with fusion might improve the efficiency of needle guidance.
In young healthy normal-weighted volunteers, however, ade-
quate ultrasonographic quality is achieved with a higher fre-
quency thus making the MRI scan, image fusion, and needle
navigation redundant. Nonetheless, we assessed the fusion
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guided technique in healthy volunteers instead of clinical
patients, because only ultrasound/MRI fusion of the lumbar
spine, and not fusion guided lumbar needle insertions, has
been briefly described in phantoms and volunteers before
[17]. Furthermore, the body position of the subjects was
different during the MRI sampling and the ultrasound/MRI
fusion guided needle procedure. This may have affected
the topography and dimensional stability of the anatomical
structures under study, and hence the accuracy of the ultra-
sound/MRI fusion guided injection [15, 19]. However, we
sampled the MRI dataset supine because this is technically
and clinically most optimal. Moreover, anymisalignment can
be manually adjusted and a pilot study revealed no evidence
that the target nerves, situated paravertebral to the rigid lum-
bar spine, moved significantly during change from supine to
lateral decubitus. Yet, we cannot fully rule out such an effect.
4.2. Block Procedure-Related Outcomes. The prolonged time
for the ultrasound/MRI fusion guided technique is in keeping
with previous studies concerning real-time fusion [14]. It
is explained by the extra time spent on coregistration and
alignment of the datasets and on needle navigation. It is also
reflected by the higher mean marginal cost and prolonged
1.5 T MRI time use of the fusion guided technique. Notably,
both success rate and procedure time of a new technique
follow a learning curve and technical perfection requires
practice [14].
4.3. MRI Analysis of Injectate Spread versus Sensorimotor
Blockade. Weobserved spread of injectate inside three fascial
compartments. The first compartment is medial to the psoas
major muscle and the iliopsoas compartment [28] (Figure 3).
We therefore suggest referring to this as the parapsoas
compartment (PPC). We observed that the PPC extends from
the level of the neural foramen of vertebra L4 cranially to
the neural foramen of S1 caudally. Caudal to the transverse
process of L5, the iliopsoas fascia is tied down to the sacral ala
and separates the PPC from the iliopsoas compartment [28].
The PPC contains the anterior rami of spinal nerves L4-S1,
the lumbosacral trunk, and the obturator nerve. The second
compartment is a triangular groove that extends from the
transverse process of L5 and the iliolumbar ligament cranially
and between the psoas major and iliac muscles until they
become fused as the iliopsoas muscle caudally (Figure 4).
The compartment is bounded by the iliopsoas fascia, which
medially separates it from the PPC and laterally covers the
groove between the psoas major and iliacus muscles. It has
been described previously [29], however, as it is a subcom-
partment of the iliopsoas compartment, we suggest referring
to this as the retropsoas subcompartment (RPSC). The RPSC
contains the femoral and lateral femoral cutaneous nerves, as
they emerge from the posterolateral border of the psoasmajor
muscle caudal to the level of the iliac crest.The third compart-
ment is the retroperitoneal fat-pad compartment between
the peritoneum and the transversalis fascia and lateral to the
iliopsoas compartment (Figure 5). We suggest referring to
this as the retroperitoneal compartment (RC).TheRC contains
none of the major terminal lumbar plexus nerves.
In all subjects, the injectate spread primarily into one or
two of the three identified compartments. Hence the injectate
primarily spread perineurally around the anterior rami of
spinal nerves L4-S1, the lumbosacral trunk and the obturator
nerve inside the PPC, around the femoral and lateral femoral
cutaneous nerves inside the RPSC, or around no nerves
inside the RC. Injectate spread inside the PPC therefore
resulted in increased sensorimotor blockade of primarily
the anterior rami of spinal nerves L4-S1, the lumbosacral
trunk (superior gluteal nerves), and the obturator nerve,
while injectate spread inside the RPSC resulted in increased
sensorimotor blockade of primarily the femoral and lateral
femoral cutaneous nerves. Injectate spread inside the RC had
no sensorimotor effect since the compartment contains no
major terminal nerves of the lumbosacral plexus.
Few previous studies have compared ultrasonography
and MRI of the lumbosacral anatomy [30] and analyzed
injectate spread with MRI [9, 31, 32]. The sensory mapping
demonstrated segmental anesthesia from L2 to S1 in accor-
dance with the perineural spread analyzed byMRI. A cadaver
study on lumbosacral plexus blockade guided by anatomical
landmarks showed weak staining of spinal nerve S1 in only
3/20 (15%) cadavers [7]. In contrast, our study demonstrates
that an injection at the neuraxial level of L5/S1 may indeed
block the cranial part of the sacral plexus.
Nonetheless, sensory mapping of dermatomes should be
interpreted with caution because it may be unreliable due
to anatomical variation and overlapping of innervation of
adjacent cutaneous segments and terminal nerves territories
[33]. We used motor blockade as a surrogate of sensory
blockade of the femoral nerve, obturator nerve, and the
lumbosacral trunk. However, the motor blockade definition
does not take account for bi- and triple nerve innervation of
specific muscle groups or measurement error of the method
to estimate muscle force. Because knowledge concerning
the correlation between reduced muscle force in healthy
volunteers and sufficient motor blockade in clinical patients
is sparse, the values of block success should be considered as
a measure of comparison of the techniques, not as a clinically
applicable measure. Due to this complexity, we recommend
inclusion of an objective analysis such as MRI recordings of
injectate spread when validating new techniques in healthy
volunteers.
4.4. Compartmentalized Injectate Spread and a Theoretical
Ultrasound/MRI Fusion Guided Anterior Approach. TheMRI
recordings allow analysis of patterns of injectate spread,
which together with high-resolution MRI for fusion with
real-time ultrasound offer the potential of improved under-
standing of the (ultrasonographic) anatomy [16]. In the
present study, we identified characteristic patterns of injectate
spread in the different fascial compartments. The observed
patterns of spread imply that local anesthetic has to be
injected into the PPC as well as the RPSC for sufficient spread
to all target nerves relevant for anesthesia of the hip joint
with a high clinical success rate. However, the visualization
of the PPC and RPSC is impeded by bony structures when
the ultrasound guided SSPS technique is employed. Further-
more, in the lateral decubitus position with the side to be
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Figure 7: Axial diffusion weighted MRI at the level of the cranial
border of the sacral ala, demonstrating a possible anterior approach
to the lumbosacral plexus in the supine position. A needle (white
arrow) can be inserted close to the anterior superior iliac spine
and advanced between the psoas major and iliacus muscles. A first
injection of local anesthetic into the retropsoas subcompartment will
spread to the femoral nerve (red arrow) and the lateral femoral cuta-
neous nerve (green arrow). A second injection of local anesthetic
into the parapsoas compartment will spread to the anterior rami of
spinal nerves L4 and L5, the lumbosacral trunk (yellow arrow) and
the obturator nerve (pink arrow).
anesthetized facing upwards, gravity may facilitate medial
spread of the local anesthetic to the epidural space [34].
An ultrasound/MRI fusion guided anterior technique in the
supine position may overcome these limitations and supply a
safe, efficient, and easy needle path from the skin surface to
the target nerves inside the PPC as well as the RPSC (Figures
7 and 8).
4.5. Pharmacokinetics of p-Lidocaine. The mean 𝐶max of p-
lidocaine was similar for the techniques and peaked approx-
imately one hour after injection. This is in keeping with
previous studies investigating plasma concentration of local
anesthetics in regional anesthesia [9, 32, 35]. No dose-finding
studies have been conducted for the SSPS technique, but the
minimal effective anesthetic volume of 0.5% ropivacaine to
accomplish a successful Shamrock lumbar plexus blockade in
95% of patients (ED95) is 36.0mL (95% CI 19.7 to 52.2) [36].
Because the aim of this study was to compare two techniques
in a standardized setting, and not to achieve maximum block
success, and the subjects were discharged on the same day,
we chose a comparatively low dose of 20mL 2% lidocaine-
epinephrine corresponding approximately to the ED50 of
0.5% ropivacaine [36] and allowing fast discharge. However,
injection of more clinical relevant local anesthetic volumes
in excess of 20mL would result in increased 𝐶max. Also,
pharmacokinetics of local anesthetic changes with age [37].
The present results might therefore not be directly applicable
in elderly patients.
4.6. Limitations. Apart from the external limitations above,
the expert anesthetist performing all blocks could not be
blinded, as is the case with all procedure-related studies. In
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Figure 8: The anterior lumbosacral plexus approach guided by
real-time ultrasound/MRI fusion in an anticipated experimental
setting. (a) The probe is axially oriented, slightly rotated clock-
wise, and medial to the anterior superior iliac spine where the
phantom needle is oriented in-plane with the US/MR image planes.
(b) Fused real-time ultrasound (b1) and MRI (b2) depicting the
needle trajectory into the retropsoas subcompartment. (c) Fused real-
time ultrasound (c1) and MRI (c2) depicting the needle trajectory
through the psoas major muscle (PMM) into the parapsoas com-
partment. Guided by real-time ultrasound/MRI fusion and needle
navigation, the “insertion point” and angulation of the phantom
needle are adjusted until the anticipated intersection between the
needle tip and the ultrasound beam (green circle) coincides with
the target lumbosacral plexus nerves in the retropsoas compartment
(b) and in the parapsoas subcompartment (c) anterior to the border
of the sacral ala (S). The line of small blue and yellow dots marks
the anticipated trajectory of the block needle prior to and after the
intersection with the ultrasound beam, respectively.
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order to limit this source of bias, we adhered to a strict
double-controlled protocol.
4.7. Perspectives. Ultrasound/MRI fusion for needle guidance
in the lumbosacral region is an evolving technique and
is proven to be neither more inaccurate nor more unsafe
compared to ultrasound guidance. Future studies of real-
time ultrasound/MRI needle guidance may include auto-
matic coregistration based on image recognition or MRI-
compatible external fiducials, or techniques thatminimise the
effect of position change and thereby improving the accuracy,
time-efficiency, and ease-of-performance.
4.8. Conclusion. The ultrasound/MRI fusion guided SSPS
technique was equally effective and safe but required longer
time, compared to the ultrasound guided SSPS technique.
Three patterns of compartmentalized injectate spread indi-
cate that local anesthetic has to be injected into the parapsoas
compartment as well as the retropsoas subcompartment to
block the lumbosacral nerves innervating the hip joint.
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